Amino Acid PET Imaging with 18F-DOPA in the evaluation of Pediatric Brain Tumors. Academic Article

abstract

• Although MRI is the workhorse of brain tumor initial evaluation and follow-up, there is a growing amount of data recommending the incorporation of amino-acid PET imaging at different stages of the management of these patients. Recent nuclear medicine and neuro-oncology clinical practice recommendations support the use of amino-acid imaging in brain tumor imaging. Considering 18F-DOPA is FDA approved for the evaluation of parkinsonian syndromes, it could be used clinically for other valuable clinical indications such as brain tumor evaluations. This value seems to be well established in adults and has growing evidence for its use in pediatrics as well. We offer to present four pediatric brain tumor cases imaged with 18F-DOPA and review the literature.

authors

• Bouhali, Othmane

published proceedings

• J Nucl Med Technol

author list (cited authors)

• Djekidel, M., Alsadi, R., Bouhali, O., & Maaz, A.

citation count

• 0

complete list of authors

• Djekidel, Mehdi||Alsadi, Rahaf||Bouhali, Othmane||Maaz, Ata Ur Rehman

publication date

• April 2022

publisher

• Society of Nuclear Medicine  Publisher

published in

• Journal of Nuclear Medicine Technology  Journal

keywords

• Amino Acid Imaging
• Brain Tumors
• Correlative Imaging
• Molecular Imaging
• Mri
• Nuclear Medicine
• Oncology: Brain
• PET
• Pediatrics
• Pet/ct
• Pet/mri
• Radiation Therapy Planning

PubMed Central ID

• 35440479

Digital Object Identifier (DOI)

• 10.2967/jnmt.121.263050

start page

• 137

end page

• 142

volume

• 50

issue

• 2

URL

• http://dx.doi.org/10.2967/jnmt.121.263050